Concepedia

Beth D. Youngblood

BD

Statistics

Publications

11

Citations

469

H-Index

11

Active since

2014

Affiliations

Amgen (United States)(Current)

Medical College of Wisconsin

AbbVie (United States)

Beth D. Youngblood is an author at Amgen (United States) specializing in pharmacology, drug discovery, and molecular pharmacology.

Publications per year

2014–2019

11

Publications

11

Transient Receptor Potential Channel Ankyrin-1 Is Not a Cold Sensor for Autonomic Thermoregulation in Rodents

Cristiane de Oliveira, András Garami, Sonya G. Lehto et al. · Journal of Neuroscience · 2014 · 68 citations · Full text

, , +17

Discovery of TRPM8 Antagonist (<i>S</i>)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine

Daniel B. Horne, Kaustav Biswas, James Brown et al. · Journal of Medicinal Chemistry · 2018 · 61 citations · Full text

, , +15

Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity

Laurie B. Schenkel, Philip R. Olivieri, Alessandro A. Boezio et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +17

Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities

Matthew M. Weiss, Thomas A. Dineen, Isaac E. Marx et al. · Journal of Medicinal Chemistry · 2017 · 49 citations · Full text

, , +14

Optimization of Potency and Pharmacokinetic Properties of Tetrahydroisoquinoline Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists

Daniel B. Horne, Nuria Tamayo, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2014 · 42 citations · Full text

, , +17

1–5 of 11